Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Hospital burden of pulmonary arterial hypertension in France.

Bergot E, De Leotoing L, Bendjenana H, Tournier C, Vainchtock A, Nachbaur G, Humbert M.

PLoS One. 2019 Sep 19;14(9):e0221211. doi: 10.1371/journal.pone.0221211. eCollection 2019.

2.

[Out of standard dyspnea].

D'Arco L, Seyer L, Fages T, Aouba A, Bergot E, Audemard-Verger A.

Rev Mal Respir. 2019 Sep;36(7):906-908. doi: 10.1016/j.rmr.2019.06.004. Epub 2019 Jul 10. French. No abstract available.

PMID:
31301923
3.

Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.

Brosseau S, Danel C, Scherpereel A, Mazières J, Lantuejoul S, Margery J, Greillier L, Audigier-Valette C, Gounant V, Antoine M, Moro-Sibilot D, Rouquette I, Molinier O, Corre R, Monnet I, Langlais A, Morin F, Bergot E, Zalcman G, Levallet G.

Clin Lung Cancer. 2019 Sep;20(5):e564-e575. doi: 10.1016/j.cllc.2019.04.010. Epub 2019 May 13.

PMID:
31279641
4.

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.

Keller M, Dubois F, Teulier S, Martin APJ, Levallet J, Maille E, Brosseau S, Elie N, Hergovich A, Bergot E, Camonis J, Zalcman G, Levallet G.

J Exp Clin Cancer Res. 2019 Apr 12;38(1):158. doi: 10.1186/s13046-019-1145-8.

5.

In vivo probe-based confocal laser endomicroscopy in chronic interstitial lung diseases: Specific descriptors and correlation with chest CT.

Salaün M, Guisier F, Dominique S, Genevois A, Jounieaux V, Bergot E, Thill C, Piton N, Thiberville L.

Respirology. 2019 Aug;24(8):783-791. doi: 10.1111/resp.13507. Epub 2019 Feb 27.

PMID:
30811085
6.

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.

Maille E, Brosseau S, Hanoux V, Creveuil C, Danel C, Bergot E, Scherpereel A, Mazières J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Langlais A, Morin F, Levallet G, Zalcman G.

Br J Cancer. 2019 Feb;120(4):387-397. doi: 10.1038/s41416-019-0379-8. Epub 2019 Feb 11.

PMID:
30739911
7.

A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control.

Dubois F, Jean-Jacques B, Roberge H, Bénard M, Galas L, Schapman D, Elie N, Goux D, Keller M, Maille E, Bergot E, Zalcman G, Levallet G.

Cell Commun Signal. 2018 Oct 11;16(1):66. doi: 10.1186/s12964-018-0276-4.

8.

[Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis].

Bergot E, Abiteboul D, Andréjak C, Antoun F, Barras E, Blanc FX, Bourgarit A, Charlois-Ou C, Delacourt C, Dirou S, Gerin M, Guerin S, Haustraete É, Henry B, Lucet JC, Maitre T, Morin J, Le Palud P, Pommelet V, Rivoisy C, Robert J, Veziris N, Herrmann JL.

Rev Mal Respir. 2018 Oct;35(8):852-858. doi: 10.1016/j.rmr.2018.08.007. Epub 2018 Sep 14. French. No abstract available.

PMID:
30224215
9.

[Interferon gamma release assay (IGRA) tests].

Le Palud P, Herrmann JL, Bergot E.

Rev Mal Respir. 2018 Oct;35(8):862-865. doi: 10.1016/j.rmr.2018.08.010. Epub 2018 Sep 15. French. No abstract available.

PMID:
30224210
10.

[Near-drowning associated Aeromonas pneumonia].

Fouquet H, Guimas M, Teulier S, Testaert H, Bergot E, Reviron-Rabec L.

Rev Mal Respir. 2018 Nov;35(9):959-962. doi: 10.1016/j.rmr.2018.08.004. Epub 2018 Sep 13. French.

PMID:
30220490
11.

Diversity of innate immune cell subsets across spatial and temporal scales in an EAE mouse model.

Caravagna C, Jaouën A, Desplat-Jégo S, Fenrich KK, Bergot E, Luche H, Grenot P, Rougon G, Malissen M, Debarbieux F.

Sci Rep. 2018 Mar 23;8(1):5146. doi: 10.1038/s41598-018-22872-y.

12.

Phosphoinositides regulate the TCR/CD3 complex membrane dynamics and activation.

Chouaki-Benmansour N, Ruminski K, Sartre AM, Phelipot MC, Salles A, Bergot E, Wu A, Chicanne G, Fallet M, Brustlein S, Billaudeau C, Formisano A, Mailfert S, Payrastre B, Marguet D, Brasselet S, Hamon Y, He HT.

Sci Rep. 2018 Mar 21;8(1):4966. doi: 10.1038/s41598-018-23109-8.

13.

Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.

Lebasnier A, Legallois D, Bienvenu B, Bergot E, Desmonts C, Zalcman G, Agostini D, Manrique A.

Ann Nucl Med. 2018 Jun;32(5):319-327. doi: 10.1007/s12149-018-1250-3. Epub 2018 Mar 20.

PMID:
29560563
14.

[About atypic tissular mass].

Guimas M, Le Palud P, Bergot E.

Rev Pneumol Clin. 2018 Apr;74(2):115-117. doi: 10.1016/j.pneumo.2018.01.001. French. No abstract available.

PMID:
29402487
15.

Heart rate and risk of death among patients with Pulmonary Hypertension: A 12-lead ECG analysis.

Bouchery-Bardet H, Creveuil C, Bauer F, Beygui F, Champ-Rigot L, Saloux E, Labombarda F, Roule V, Sabatier R, Legallois D, Zalcman G, Bergot E, Milliez P.

Respir Med. 2017 Nov;132:42-49. doi: 10.1016/j.rmed.2017.09.008. Epub 2017 Sep 22.

PMID:
29229104
16.

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.

Boucly A, Cottin V, Nunes H, Jaïs X, Tazi A, Prévôt G, Reynaud-Gaubert M, Dromer C, Viacroze C, Horeau-Langlard D, Pison C, Bergot E, Traclet J, Weatherald J, Simonneau G, Valeyre D, Montani D, Humbert M, Sitbon O, Savale L.

Eur Respir J. 2017 Oct 19;50(4). pii: 1700465. doi: 10.1183/13993003.00465-2017. Print 2017 Oct.

17.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. 2017 update. Full-length update].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 21. pii: S0761-8425(17)30209-7. doi: 10.1016/j.rmr.2017.07.018. [Epub ahead of print] French. No abstract available.

18.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Full-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):900-968. doi: 10.1016/j.rmr.2017.07.017. Epub 2017 Sep 20. No abstract available.

PMID:
28939155
19.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Short-length version.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):852-899. doi: 10.1016/j.rmr.2017.07.019. Epub 2017 Sep 20. No abstract available.

PMID:
28939154
20.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Short-length version].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 18. pii: S0761-8425(17)30211-5. doi: 10.1016/j.rmr.2017.07.020. [Epub ahead of print] French. No abstract available.

PMID:
28935497
21.

[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary].

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Sep 19. pii: S0761-8425(17)30212-7. doi: 10.1016/j.rmr.2017.07.021. [Epub ahead of print] French. No abstract available.

PMID:
28935496
22.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary.

Cottin V, Crestani B, Cadranel J, Cordier JF, Marchand-Adam S, Prévot G, Wallaert B, Bergot E, Camus P, Dalphin JC, Dromer C, Gomez E, Israel-Biet D, Jouneau S, Kessler R, Marquette CH, Reynaud-Gaubert M, Aguilaniu B, Bonnet D, Carré P, Danel C, Faivre JB, Ferretti G, Just N, Lebargy F, Philippe B, Terrioux P, Thivolet-Béjui F, Trumbic B, Valeyre D.

Rev Mal Respir. 2017 Oct;34(8):834-851. doi: 10.1016/j.rmr.2017.07.022. Epub 2017 Sep 19. No abstract available.

PMID:
28935495
23.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.

Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug.

24.

Predicting susceptibility to tuberculosis based on gene expression profiling in dendritic cells.

Blischak JD, Tailleux L, Myrthil M, Charlois C, Bergot E, Dinh A, Morizot G, Chény O, Platen CV, Herrmann JL, Brosch R, Barreiro LB, Gilad Y.

Sci Rep. 2017 Jul 18;7(1):5702. doi: 10.1038/s41598-017-05878-w.

25.

MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early-stage lung cancer patients from the IFCT-0002 Phase 3 Trial.

Levallet G, Dubois F, Fouret P, Antoine M, Brosseau S, Bergot E, Beau-Faller M, Gounant V, Brambilla E, Debieuvre D, Molinier O, Galateau-Sallé F, Mazieres J, Quoix E, Pujol JL, Moro-Sibilot D, Langlais A, Morin F, Westeel V, Zalcman G.

Oncotarget. 2017 Jan 17;8(3):4313-4329. doi: 10.18632/oncotarget.14025.

26.

The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells.

Roncagalli R, Cucchetti M, Jarmuzynski N, Grégoire C, Bergot E, Audebert S, Baudelet E, Menoita MG, Joachim A, Durand S, Suchanek M, Fiore F, Zhang L, Liang Y, Camoin L, Malissen M, Malissen B.

J Exp Med. 2016 Oct 17;213(11):2437-2457. Epub 2016 Sep 19.

27.

Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey.

Cottin V, Bergot E, Bourdin A, Cadranel J, Camus P, Crestani B, Dalphin JC, Delaval P, Dromer C, Israel-Biet D, Kessler R, Marchand-Adam S, Marquette CH, Prévot G, Reynaud-Gaubert M, Valeyre D, Wallaert B, Bouquillon B, Cordier JF.

ERJ Open Res. 2015 Nov 16;1(2). pii: 00032-2015. eCollection 2015 Oct.

28.

Heart involvement in cystic fibrosis: A specific cystic fibrosis-related myocardial changes?

Labombarda F, Saloux E, Brouard J, Bergot E, Milliez P.

Respir Med. 2016 Sep;118:31-38. doi: 10.1016/j.rmed.2016.07.011. Epub 2016 Jul 15. Review.

29.

Co-recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR-induced ubiquitylation.

Voisinne G, García-Blesa A, Chaoui K, Fiore F, Bergot E, Girard L, Malissen M, Burlet-Schiltz O, Gonzalez de Peredo A, Malissen B, Roncagalli R.

Mol Syst Biol. 2016 Jul 29;12(7):876. doi: 10.15252/msb.20166837.

30.

Neurological involvement in hereditary hemorrhagic telangiectasia.

Labeyrie PE, Courthéoux P, Babin E, Bergot E, Touzé E, Pelage JP.

J Neuroradiol. 2016 Jul;43(4):236-45. doi: 10.1016/j.neurad.2016.02.005. Epub 2016 Apr 5. Review.

PMID:
27059009
31.

Initial dual oral combination therapy in pulmonary arterial hypertension.

Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jaïs X, De Groote P, Chaouat A, Chabannes C, Bergot E, Bouvaist H, Dauphin C, Bourdin A, Bauer F, Montani D, Humbert M, Simonneau G.

Eur Respir J. 2016 Jun;47(6):1727-36. doi: 10.1183/13993003.02043-2015. Epub 2016 Mar 17.

32.

Pulmonary complications of type 1 neurofibromatosis.

Reviron-Rabec L, Girerd B, Seferian A, Campbell K, Brosseau S, Bergot E, Humbert M, Zalcman G, Montani D.

Rev Mal Respir. 2016 Jun;33(6):460-73. doi: 10.1016/j.rmr.2014.09.010. Epub 2016 Feb 8. Review.

PMID:
26868668
33.

A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.

Sanges S, Launay D, Rhee RL, Sitbon O, Hachulla É, Mouthon L, Guillevin L, Rottat L, Montani D, De Groote P, Cottin V, Magro P, Prévot G, Bauer F, Bergot E, Chabanne C, Reynaud-Gaubert M, Leroy S, Canuet M, Sanchez O, Gut-Gobert C, Dauphin C, Pison C, Boissin C, Habib G, Clerson P, Conesa F, Cordier JF, Kawut SM, Simonneau G, Humbert M.

Ann Rheum Dis. 2016 Aug;75(8):1457-65. doi: 10.1136/annrheumdis-2015-207336. Epub 2015 Aug 31.

PMID:
26324844
34.

Antecubital vs Femoral Venous Access for Right Heart Catheterization: Benefits of a Flashback.

Roule V, Ailem S, Legallois D, Dahdouh Z, Lognoné T, Bergot E, Grollier G, Milliez P, Sabatier R, Beygui F.

Can J Cardiol. 2015 Dec;31(12):1497.e1-6. doi: 10.1016/j.cjca.2015.04.026. Epub 2015 Apr 30.

PMID:
26277087
35.

Tricuspid systolic peak velocity is a prognostic factor in patients with cystic fibrosis.

Labombarda F, Barigou A, Legallois D, Campbell K, Bergot E, Milliez P, Saloux E.

Int J Cardiol. 2015 Nov 15;199:435-6. doi: 10.1016/j.ijcard.2015.07.088. Epub 2015 Jul 30. No abstract available.

PMID:
26263010
36.

[Tuberculosis in 2015: From diagnosis to the detection of multiresistant cases].

Hervé C, Bergot E, Veziris N, Blanc FX.

Rev Mal Respir. 2015 Oct;32(8):784-90. doi: 10.1016/j.rmr.2015.06.008. Epub 2015 Jul 10. Review. French.

PMID:
26169235
37.

Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation.

Bergeron A, Chevret S, Chagnon K, Godet C, Bergot E, Peffault de Latour R, Dominique S, de Revel T, Juvin K, Maillard N, Reman O, Contentin N, Robin M, Buzyn A, Socié G, Tazi A.

Am J Respir Crit Care Med. 2015 Jun 1;191(11):1242-9. doi: 10.1164/rccm.201410-1818OC.

PMID:
25835160
38.

[Dasatinib-related pneumonia? An example of pharmacovigilance survey].

Audemard A, de la Gastine B, Chantepie S, Verger H, Gac AC, Bergot E, Reman O.

Rev Mal Respir. 2015 Jan;32(1):84-6. doi: 10.1016/j.rmr.2014.08.002. Epub 2014 Sep 26. French. No abstract available.

PMID:
25618211
39.

Severe hematologic complications after lung transplantation in patients with telomerase complex mutations.

Borie R, Kannengiesser C, Hirschi S, Le Pavec J, Mal H, Bergot E, Jouneau S, Naccache JM, Revy P, Boutboul D, Peffault de la Tour R, Wemeau-Stervinou L, Philit F, Cordier JF, Thabut G, Crestani B, Cottin V; Groupe d’Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P).

J Heart Lung Transplant. 2015 Apr;34(4):538-46. doi: 10.1016/j.healun.2014.11.010. Epub 2014 Nov 13.

40.

Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis.

Le Palud P, Cattoir V, Malbruny B, Magnier R, Campbell K, Oulkhouir Y, Zalcman G, Bergot E.

BMC Pulm Med. 2014 Aug 12;14:137. doi: 10.1186/1471-2466-14-137.

41.

Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.

Sitbon O, Jaïs X, Savale L, Cottin V, Bergot E, Macari EA, Bouvaist H, Dauphin C, Picard F, Bulifon S, Montani D, Humbert M, Simonneau G.

Eur Respir J. 2014 Jun;43(6):1691-7. doi: 10.1183/09031936.00116313. Epub 2014 Mar 13.

42.

Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.

Bergot E, Sitbon O, Cottin V, Prévot G, Canuet M, Bourdin A, de Groote P, Rottat L, Gressin V, Jaïs X, Humbert M, Simonneau G.

Int J Cardiol. 2014 Apr 1;172(3):561-7. doi: 10.1016/j.ijcard.2013.12.313. Epub 2014 Jan 22.

PMID:
24529947
43.

EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension.

Sitbon O, Delcroix M, Bergot E, Boonstra AB, Granton J, Langleben D, Subías PE, Galiè N, Pfister T, Lemarié JC, Simonneau G.

Am Heart J. 2014 Feb;167(2):210-7. doi: 10.1016/j.ahj.2013.08.007. Epub 2013 Oct 3.

44.

Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy.

Bergot E, Levallet G, Campbell K, Dubois F, Lechapt E, Zalcman G.

Eur Respir Rev. 2013 Dec;22(130):565-76. doi: 10.1183/09059180.00007113. Review.

45.

[Malignant pleural mesothelioma: 2013 state of the art].

Campbell K, Brosseau S, Reviron-Rabec L, Bergot E, Lechapt E, Levallet G, Zalcman G.

Bull Cancer. 2013 Dec;100(12):1283-93. doi: 10.1684/bdc.2013.1857. Review. French.

PMID:
24225007
46.

[Interest of collapse therapy in pulmonary extensively drug-resistant tuberculosis].

Haustraete E, Campbell K, Magnier R, Zalcman G, Bergot É.

Rev Pneumol Clin. 2014 Aug;70(4):240-4. doi: 10.1016/j.pneumo.2013.08.007. Epub 2013 Nov 5. French.

PMID:
24210158
47.

Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?

Godinas L, Guignabert C, Seferian A, Perros F, Bergot E, Sibille Y, Humbert M, Montani D.

Semin Respir Crit Care Med. 2013 Oct;34(5):714-24. doi: 10.1055/s-0033-1356494. Epub 2013 Sep 13. Review.

PMID:
24037637
48.

In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia.

Salaün M, Roussel F, Bourg-Heckly G, Vever-Bizet C, Dominique S, Genevois A, Jounieaux V, Zalcman G, Bergot E, Vergnon JM, Thiberville L.

Eur Respir J. 2013 Dec;42(6):1646-58. doi: 10.1183/09031936.00191911. Epub 2012 Sep 27.

49.

Observational study of QuantiFERON®-TB gold in-tube assay in tuberculosis contacts in a low incidence area.

Bergot E, Haustraete E, Malbruny B, Magnier R, Salaün MA, Zalcman G.

PLoS One. 2012;7(8):e43520. doi: 10.1371/journal.pone.0043520. Epub 2012 Aug 24.

50.

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.

Cadranel J, Philippe B, Hennequin C, Bergeron A, Bergot E, Bourdin A, Cottin V, Jeanfaivre T, Godet C, Pineau M, Germaud P.

Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3231-9. doi: 10.1007/s10096-012-1690-y. Epub 2012 Jul 11.

Supplemental Content

Loading ...
Support Center